Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Lipid Research|May 14, 2020
Liver-specific ceramide reduction alleviates steatosis and insulin resistance in alcohol-fed miceJason Correnti, Chelsea Lin, Jascha Brettschneider, et al.
Contemporary Clinical Trials|May 23, 2018
Design and rationale of the INSYTE study: A randomised, placebo controlled study to test the efficacy of a synbiotic on liver fat, disease biomarkers and intestinal microbiota in non-alcoholic fatty liver diseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Plos One|May 3, 2023
Concomitant western diet and chronic-binge alcohol dysregulate hepatic metabolismDelfin Gerard Buyco, Joseph L Dempsey, Eleonora Scorletti, et al.
Hepatology Communications|September 14, 2023
Aspirin is associated with a reduced incidence of liver disease in menMara Sophie Vell, Arunkumar Krishnan, Kirk Wangensteen, et al.
Med (New York, N.Y.)|May 22, 2024
The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLDMiriam Daphne Rendel, Cecilia Vitali, Kate Townsend Creasy, et al.
Alimentary Pharmacology & Therapeutics|May 30, 2023
A coding variant in the microsomal triglyceride transfer protein reduces both hepatic steatosis and plasma lipidsCarolin V Schneider, Leonida Hehl, Kate T Creasy, et al.
JAMA Network Open|June 26, 2023
Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related MortalityMara Sophie Vell, Rohit Loomba, Arunkumar Krishnan, et al.
Eclinicalmedicine|August 21, 2023
Large-scale identification of undiagnosed hepatic steatosis using natural language processingCarolin V Schneider, Tang Li, David Zhang, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
A missense variant in human perilipin 2 (PLIN2 Ser251Pro) reduces hepatic steatosis in miceEleonora Scorletti, Yedidya Saiman, Sookyoung Jeon, et al.
Gastroenterology|January 29, 2020
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver DiseaseEleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, et al.
Pageof 6